MK-4815, a Potential New Oral Agent for Treatment of Malaria
Antimicrobial Agents and Chemotherapy, 04/25/2012Powles MA et al.
MK–4815 is inexpensive to synthesize, an important characteristic for providing affordable antimalaria therapy to the developing world. The attractive biological and pharmaceutical profile of MK–4815 demonstrates its potential for use in combination with other agents in the fight against malaria.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.